Published in Technol Cancer Res Treat on July 01, 2015
Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol. BMC Cancer (2017) 0.75
Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study. Phys Med Biol (2016) 0.75
Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study. Technol Cancer Res Treat (2016) 0.75
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology (1986) 11.58
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging (1997) 6.77
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med (2006) 3.63
Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol (2004) 3.63
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol (2001) 2.89
Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med (2000) 2.75
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol (2006) 2.72
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys (2005) 2.41
Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst (2001) 2.05
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol (2012) 2.01
Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys (2006) 1.94
Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol (2005) 1.69
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys (2010) 1.67
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys (2006) 1.66
Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2009) 1.65
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat (2004) 1.62
Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med (2004) 1.56
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51
Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future. Int J Radiat Oncol Biol Phys (2010) 1.50
Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging (2005) 1.49
Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging (2008) 1.48
Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med (2007) 1.48
Water diffusion in the different microenvironments of breast cancer. NMR Biomed (2004) 1.40
Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans (2008) 1.39
Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed (2002) 1.34
Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging (2006) 1.27
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. Phys Med Biol (2010) 1.14
T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging (2007) 1.14
Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics (2006) 1.12
Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory. Med Phys (2010) 1.10
MRI for assessing antivascular cancer treatments. Br J Radiol (2003) 1.10
Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol (2005) 1.08
Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS. NMR Biomed (2010) 1.06
Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI. Med Phys (2010) 1.05
Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol (2006) 1.01
Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI. IEEE Trans Med Imaging (2011) 0.98
DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study. Int J Hyperthermia (2009) 0.96
Functional magnetic resonance: biomarkers of response in breast cancer. Breast Cancer Res (2011) 0.91
Review of treatment assessment using DCE-MRI in breast cancer radiation therapy. World J Methodol (2014) 0.86
Rigid point feature registration using mutual information. Med Image Anal (1999) 0.76
On the sensitivity of TG-119 and IROC credentialing to TPS commissioning errors. J Appl Clin Med Phys (2016) 0.75
Diode-based transmission detector for IMRT delivery monitoring: a validation study. J Appl Clin Med Phys (2016) 0.75
Sensitivity of 3D Dose Verification to Multileaf Collimator Misalignments in Stereotactic Body Radiation Therapy of Spinal Tumor. Technol Cancer Res Treat (2015) 0.75